Finally, limited evidence suggests that DCLK1-expressing intestinal TCs in the gut can promote tumor progression in hepatocellular carcinoma (HCC) through activating alternative macrophages in tumor microenvironment via secreting IL-25 [46]. Here, IL25 is linked to neoplasm.